Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Goldman Sachs

Tightness in US Crude Supplies Supports Crude Oil Prices

July WTI crude oil (CLN26 ) on Wednesday closed up +0.74 (+0.97%), and July RBOB gasoline (RBN26 ) closed up +0.0291 (+1.01%). Crude oil and gasoline prices settled higher on Wednesday, with crude recovering from a 3.5-month low. Crude oil prices rose on Wednesday on some technical buying after sharp...

Barchart

Crude Oil Prices Jump as US Domestic Supplies Tumble

July WTI crude oil (CLN26 ) today is up +0.90 (+1.18%), and July RBOB gasoline (RBN26 ) is up +0.0098 (+0.34%). Crude oil and gasoline prices are moving higher today, with crude recovering from a 3.5-month low. Crude oil prices are climbing today on some technical buying after sharp losses...

Barchart

Your raise used to go offshore. Then it went to a buyback. Now it's going to a data center

Goldman Sachs' global strategist says we've entered a "postmodern" era of finance — and the rules that made investors rich for 40 years no longer apply.

Fortune

From analysis to the latest developments in health,
read the most diverse news in one place.

Goldman Sachs shatters dealmaking records with $1 trillion in first-half M&A volume

Goldman Sachs achieved a record pace in 2026, managing over one trillion dollars in announced mergers and acquisitions. This success follows their role in SpaceX's initial public offering and advising on Dominion Energy's sale. Global M&A volumes have surpassed two point six trillion dollars this year. CEOs are strategically pursuing…

The Economic Times

Crude Oil Prices Sink as Global Oil Supplies Look to Normalize

July WTI crude oil (CLN26 ) on Tuesday closed down -4.70 (-5.83%), and July RBOB gasoline (RBN26 ) closed down -0.0667 (-2.26%). Crude oil and gasoline prices fell sharply for the fourth consecutive session on Tuesday, with crude posting a 3.5-month low and gasoline posting a 3.25-month low. Crude oil...

Barchart

College students are voting with their feet on AI. Goldman has the receipts

If you were a student right now, what major would you choose?

Fortune

Goldman’s S&P 500 Target Looks More Reachable After the Latest Rally

Goldman Sachs raised its S&P 500 year-end target to 8,000, citing EPS growth, broad earnings beats, and IPO activity including SpaceX's June 12 debut at $135 per share.

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

Chinese social media firm Xiaohongshu taps Goldman, CICC to work on Hong Kong IPO

Chinese social media platform Xiaohongshu is preparing for a potential Hong Kong initial public offering. Banks including Goldman Sachs and CICC are reportedly working on the deal. The company, also known as RedNote, could list as early as the second half of this year. This move follows a previous attempt…

The Economic Times

Nvidia to raise $25 billion in first corporate bond sale in five years

Nvidia is set to raise a massive $20 billion through a bond issuance. This move signals the company's significant investment in artificial intelligence infrastructure. Big technology firms are increasingly turning to debt markets to finance their ambitious AI projects. This bond issuance, with maturities extending to 2056, highlights the substantial…

The Economic Times

A $1.24 Trillion Reason to Buy Dell Stock Now

Dell is riding powerful AI and server tailwinds, steadily expanding market share while growth forecasts keep moving higher.

Barchart

How Musk's tactics left investors clamoring for SpaceX stock and ignoring risks

One investor said that when SpaceX was privately held, he used a connection with a cousin of the billionaire entrepreneur to buy $10 million worth of stock in the satellite maker in 2018. A portfolio manager at a $500 billion U.S. fund said he had to use his relationship with…

The Economic Times

The economist who said ‘no bubble’ just sounded the alarm: ‘The season of chaos is at hand’

“The chamber of dispersion has been opened,” Owen Lamont says. “The beast of volatility has awakened, and the season of chaos is at hand.”

Fortune

Lenskart block deal; Meesho's kirana push

Lenskart has drawn fresh interest from major institutional investors. This and more in today's ETtech Top 5.

The Economic Times

Lenskart shares in focus as Goldman Sachs, Morgan Stanley, others purchase stake in Rs 1,960 crore block deal

Lenskart Solutions saw significant stake activity as marquee investors bought Rs 1,960 crore in a block deal, with Platinum Jasmine A 2018 Trust paring its holding. Despite recent exits, brokerages remain optimistic about Lenskart's long-term growth, citing its integrated model and international expansion.

The Economic Times

Get all your
news in one place.

100's of premium titles.
One news app.

Fortune

SpaceX lowballed its bankers on fees. Goldman Sachs has another way to win big

The real money comes after the opening bell.

AAP

After record IPO, SpaceX faces test in market debut

SpaceX has made history after raising $106 billion to become the biggest IPO ever. Now the market is set to find out the strength of the stock's "Musk premium".

The Economic Times

US stocks: Musk's SpaceX prices record $75 billion IPO at $135 a share

SpaceX has priced its record-breaking U.S. IPO at $135 per share, raising $75 billion and valuing the company at $1.77 trillion. This makes it one of the world's most valuable companies, surpassing established giants. The offering, which saw significant retail allocation, culminates Elon Musk's ambitious project despite questions about its…

The Economic Times

Honasa shares jump 6% on Rs 5,500 crore revenue target by FY31. What is Goldman Sachs saying?

Honasa Consumer shares surged after the company outlined a revenue target of ₹5,500 crore by FY31. The guidance implies an annual growth rate of around 18% between FY26 and FY31. Growth is expected to be led by Mamaearth, with revenue projected to exceed ₹2,000 crore, while The Derma Co is…

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

Grain Market Update: Are Corn, Wheat, and Soybeans Finally Carving Out a Summer Bottom?

Barchart Senior Market Analyst Darin Newsom analyzes whether the morning's short-covering bounce in grains is a temporary reprieve or a permanent bottom, while breaking down the technical realities of the Goldman roll, a hot 4.2% CPI print, and the critical cash-market triggers dictating the cattle pits.

Barchart

Billionaire Sam Altman Says OpenAI Was ‘Pretty Wrong’ About AI Jobs, But Goldman Sachs Warns AI is Still Wiping Out 11,000 Jobs Per Month

The AI jobs story has become a split screen: one of the most powerful artificial intelligence (AI) executives is walking back the worst panic, while data tracked by Goldman Sachs (GS ) still points to pressure on younger white-collar workers. The lack of a clean yes-or-no answer is exactly why...

The Economic Times

Goldman Sachs buys CMR Green Technologies shares on listing day after strong debut

Goldman Sachs India Equity Portfolio bought shares worth Rs 49.82 crore in CMR Green Technologies on its listing day, which saw a 43% premium. Despite investor optimism, analysts advise caution and partial profit booking amid high valuations.

Fortune

‘The circulatory system is not working.’ Goldman on what’s really wrong with private markets

Goldman Sachs’ top private markets executives say the industry has reached a structural inflection point—not a crisis. Not everyone agrees.

Fortune

A $7 billion horse race: Goldman Sachs and Morgan Stanley battle to lead OpenAI and Anthropic IPOs

Only one bank can occupy the coveted lead underwriter position for this year's hottest AI IPOs.

The Economic Times

SpaceX aims to launch orbital AI computing tests by end of next year

During two investor presentations ahead of the IPO, both featuring President Gwynne Shotwell and Chief Financial Officer Bret Johnsen, SpaceX executives outlined a roadmap to begin demonstrating orbital-compute capabilities in 2027, according to the two people familiar with the discussions. Both sources were at a Goldman Sachs meeting and one…

MarketBeat

Amneal Pharmaceuticals Bets on Biosimilars, Patches to Power Next Growth Phase

Amneal Pharmaceuticals (NASDAQ:AMRX) Co-Founder, President and Co-Chief Executive Officer Chirag Patel said the company is entering a stronger growth phase, driven by momentum in its existing generics portfolio, a newly expanded biosimilars platform and specialty product launches. Speaking at a Gol

1 … 7 8 9 10

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Oil

33,886 stories

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.